Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DA-007 for Chemotherapy Induced Alopecia
NCT06762548Phase 3Not yet recruiting
- Start
- Oct 2027
- Primary completion
- Mar 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in Chemotherapy-induced alopecia (CIA) comparing DA-007 with Placebo (2 arms). Primary endpoint: Prevention of Hair Loss (CTCAE V5.0) at 12 weeks. Planned start Oct 2027; status: not yet recruiting.
02
Drugs
DA-007
03
Conditions
Chemotherapy-induced alopecia (CIA)
Beyond the preview
Go deeper on NCT06762548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06762548.